Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
Paoluzi OA, Iacopini F, Pica R, Crispino P, Marcheggiano A, Consolazio A, Rivera M, Paoluzi P. Paoluzi OA, et al. Among authors: paoluzi p. Aliment Pharmacol Ther. 2005 May 1;21(9):1111-9. doi: 10.1111/j.1365-2036.2005.02458.x. Aliment Pharmacol Ther. 2005. PMID: 15854173 Free article. Clinical Trial.
Overexpression of fatty acid synthase in ulcerative colitis.
Consolazio A, Alò PL, Rivera M, Iacopini F, Paoluzi OA, Crispino P, Pica R, Paoluzi P. Consolazio A, et al. Among authors: paoluzi oa, paoluzi p. Am J Clin Pathol. 2006 Jul;126(1):113-8. doi: 10.1309/pubvqndnvqkjvc8m. Am J Clin Pathol. 2006. PMID: 16753600
Short-chain fatty acid topical treatment in distal ulcerative colitis.
Vernia P, Marcheggiano A, Caprilli R, Frieri G, Corrao G, Valpiani D, Di Paolo MC, Paoluzi P, Torsoli A. Vernia P, et al. Among authors: paoluzi p. Aliment Pharmacol Ther. 1995 Jun;9(3):309-13. doi: 10.1111/j.1365-2036.1995.tb00386.x. Aliment Pharmacol Ther. 1995. PMID: 7654893 Clinical Trial.
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
Paoluzi OA, Pica R, Marcheggiano A, Crispino P, Iacopini F, Iannoni C, Rivera M, Paoluzi P. Paoluzi OA, et al. Among authors: paoluzi p. Aliment Pharmacol Ther. 2002 Oct;16(10):1751-9. doi: 10.1046/j.1365-2036.2002.01340.x. Aliment Pharmacol Ther. 2002. PMID: 12269968 Free article. Clinical Trial.
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.
Paoluzi P, D'Albasio G, Pera A, Bianchi Porro G, Paoluzi OA, Pica R, Cottone M, Miglioli M, Prantera C, Sturniolo G, Ardizzone S. Paoluzi P, et al. Among authors: paoluzi oa. Dig Liver Dis. 2002 Nov;34(11):787-93. doi: 10.1016/s1590-8658(02)80072-x. Dig Liver Dis. 2002. PMID: 12546514 Clinical Trial.
Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis.
Consolazio A, Borgia MC, Ferro D, Iacopini F, Paoluzi OA, Crispino P, Nardi F, Rivera M, Paoluzi P. Consolazio A, et al. Among authors: paoluzi oa, paoluzi p. Aliment Pharmacol Ther. 2004 Aug 1;20(3):289-94. doi: 10.1111/j.1365-2036.2004.02074.x. Aliment Pharmacol Ther. 2004. PMID: 15274665 Free article. Clinical Trial.
75 results